History of the study of amyloidosis: from the Rokitansky’s theory to the present day

Pub Date : 2024-07-07 DOI:10.26442/00403660.2024.06.202732
V. Rameev, Lidia V. Lysenko
{"title":"History of the study of amyloidosis: from the Rokitansky’s theory to the present day","authors":"V. Rameev, Lidia V. Lysenko","doi":"10.26442/00403660.2024.06.202732","DOIUrl":null,"url":null,"abstract":"In the history of amyloidosis studying the concept of liquids dyscrasia has been predominated and finally it is resulted in accepting a serum protein-precursor as a leading amyloidogenic factor in the disease pathogenesis. Consequently basic diagnostic and treatment strategy was aimed to find and eliminate this protein from the blood and this approach evidenced high effectiveness in most frequent AA and AL-amyloidosis characterized with anomaly high levels of precursors in the blood. At the same time there are less frequent and slower progressing inheritant forms of systemic amyloidosis including transthyretin induced, which are less depending on amyloidogenecity of amyloid precursor and because of that, in example, the effectiveness of transthyretin stabilizers or blockers of its synthesis is limited comparing with the precursor elimination in AA or AL. Developed in the middle of XX century a theory of local synthesis by macrophages is more preferable to describe the pathogenesis of these forms. And modern proteome analysis using give rise to confirm the key meaning of macrophage in the amyloidogenesis and proves necessity to know deeply mechanisms of macrophagial autophagia – basic tool of maintaining intracellular protein homeostasis. That is why it is difficult to hope on high effectiveness of chemical amyloid solvents in vivo, which being under macrophages regulation never could realize its chemical activities.","PeriodicalId":0,"journal":{"name":"","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-07-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.26442/00403660.2024.06.202732","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

In the history of amyloidosis studying the concept of liquids dyscrasia has been predominated and finally it is resulted in accepting a serum protein-precursor as a leading amyloidogenic factor in the disease pathogenesis. Consequently basic diagnostic and treatment strategy was aimed to find and eliminate this protein from the blood and this approach evidenced high effectiveness in most frequent AA and AL-amyloidosis characterized with anomaly high levels of precursors in the blood. At the same time there are less frequent and slower progressing inheritant forms of systemic amyloidosis including transthyretin induced, which are less depending on amyloidogenecity of amyloid precursor and because of that, in example, the effectiveness of transthyretin stabilizers or blockers of its synthesis is limited comparing with the precursor elimination in AA or AL. Developed in the middle of XX century a theory of local synthesis by macrophages is more preferable to describe the pathogenesis of these forms. And modern proteome analysis using give rise to confirm the key meaning of macrophage in the amyloidogenesis and proves necessity to know deeply mechanisms of macrophagial autophagia – basic tool of maintaining intracellular protein homeostasis. That is why it is difficult to hope on high effectiveness of chemical amyloid solvents in vivo, which being under macrophages regulation never could realize its chemical activities.
分享
查看原文
淀粉样变性研究的历史:从罗基坦斯基的理论到今天
在淀粉样变性研究的历史上,液体发育不良的概念一直占主导地位,最终导致将血清蛋白前体视为疾病发病机制中的主要淀粉样变性因素。因此,基本诊断和治疗策略的目标是找到并消除血液中的这种蛋白质,这种方法在大多数常见的 AA 和 AL 淀粉样变性中非常有效,其特点是血液中的前体含量异常高。与此同时,也有一些发病率较低、进展较慢的遗传性系统性淀粉样变性,包括转甲状腺素诱发的系统性淀粉样变性,这些系统性淀粉样变性对淀粉样前体淀粉样蛋白发生率的依赖性较低,因此,与消除 AA 或 AL 淀粉样前体相比,转甲状腺素稳定剂或转甲状腺素合成阻断剂的效果有限。二十世纪中叶提出的巨噬细胞局部合成理论更适于描述这些形式的发病机理。现代蛋白质组分析证实了巨噬细胞在淀粉样蛋白生成过程中的关键作用,并证明有必要深入了解巨噬细胞自噬机制--维持细胞内蛋白质平衡的基本工具。这就是为什么很难指望淀粉样蛋白化学溶剂在体内具有很高的效力,因为在巨噬细胞的调控下,淀粉样蛋白化学溶剂永远无法实现其化学活性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信